{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:03:50Z","timestamp":1763726630808,"version":"3.40.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T00:00:00Z","timestamp":1351123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00213-012-2883-x","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T07:15:29Z","timestamp":1351062929000},"page":"53-63","source":"Crossref","is-referenced-by-count":18,"title":["Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers"],"prefix":"10.1007","volume":"226","author":[{"given":"Lawrence P.","family":"Carter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethea A.","family":"Kleykamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam Z.","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,25]]},"reference":[{"key":"2883_CR1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000542-199801000-00015","volume":"88","author":"TA Bowdle","year":"1998","unstructured":"Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP (1998) Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 88:82\u201388","journal-title":"Anesthesiology"},{"issue":"Suppl 1","key":"2883_CR2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.drugalcdep.2009.04.003","volume":"105","author":"LP Carter","year":"2009","unstructured":"Carter LP, Griffiths RR (2009) Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend 105(Suppl 1):S14\u2013S25","journal-title":"Drug Alcohol Depend"},{"key":"2883_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-009-1589-1","volume":"206","author":"LP Carter","year":"2009","unstructured":"Carter LP, Griffiths RR, Mintzer MZ (2009) Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacol (Berl) 206:141\u2013154","journal-title":"Psychopharmacol (Berl)"},{"key":"2883_CR4","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.npp.1301146","volume":"31","author":"LP Carter","year":"2006","unstructured":"Carter LP, Richards BD, Mintzer MZ, Griffiths RR (2006) Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacol 31:2537\u20132551","journal-title":"Neuropsychopharmacol"},{"key":"2883_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0091-3057(89)90451-6","volume":"33","author":"H deWit","year":"1989","unstructured":"deWit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharmacol Biochem Behav 33:205\u2013213","journal-title":"Pharmacol Biochem Behav"},{"key":"2883_CR6","first-page":"732","volume":"49","author":"LA Goodman","year":"1954","unstructured":"Goodman LA, Kruskal WH (1954) Measures of association for cross-classifications. JASA 49:732\u2013764","journal-title":"JASA"},{"key":"2883_CR7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/cercor\/bhh176","volume":"15","author":"GD Honey","year":"2005","unstructured":"Honey GD, Honey RA, O\u2019Loughlin C, Sharar SR, Kumaran D, Suckling J, Menon DK, Sleator C, Bullmore ET, Fletcher PC (2005) Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb Cortex 15:749\u2013759","journal-title":"Cereb Cortex"},{"key":"2883_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.npp.1300846","volume":"31","author":"GD Honey","year":"2006","unstructured":"Honey GD, O\u2019loughlin C, Turner DC, Pomarol-Clotet E, Corlett PR, Fletcher PC (2006) The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia. Neuropsychopharmacology 31:413\u2013423","journal-title":"Neuropsychopharmacology"},{"key":"2883_CR9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/0021-8294.00085","volume":"40","author":"RW Hood Jr","year":"2001","unstructured":"Hood RW Jr, Ghorbani N, Watson PJ, Ghramaleki AF, Bing MN, Davison HK, Morris RJ, Williamson WP (2001) Dimensions of the mysticism scale: confirming the three-factor structure in the United States and Iran. J Sci Study Relig 40:691\u2013705","journal-title":"J Sci Study Relig"},{"key":"2883_CR10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","volume":"22","author":"M Johnson","year":"2008","unstructured":"Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22:603\u2013620","journal-title":"J Psychopharmacol"},{"key":"2883_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s002130000626","volume":"154","author":"HE Jones","year":"2001","unstructured":"Jones HE, Garrett BE, Griffiths RR (2001) Reinforcing effects of oral cocaine: contextual determinants. Psychopharmacol (Berl) 154:143\u2013152","journal-title":"Psychopharmacol (Berl)"},{"key":"2883_CR12","unstructured":"Keppel G (1991) Design and analysis: a researcher\u2019s handbook, 3rd edn. Prentice Hall, Englewood Cliffs, NJ"},{"key":"2883_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0018407","volume":"18","author":"BA Kleykamp","year":"2010","unstructured":"Kleykamp BA, Griffiths RR, Mintzer MZ (2010) Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Exp Clin Psychopharmacol 18:1\u201316","journal-title":"Exp Clin Psychopharmacol"},{"key":"2883_CR14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1037\/0033-295X.103.3.490","volume":"103","author":"A Koriat","year":"1996","unstructured":"Koriat A, Goldsmith M (1996) Monitoring and control processes in the strategic regulation of memory accuracy. Psychol Rev 103:490\u2013517","journal-title":"Psychol Rev"},{"key":"2883_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002130050503","volume":"135","author":"JH Krystal","year":"1998","unstructured":"Krystal JH, Karper LP, Bennett A, D\u2019Souza DC, Abi-Dargham A, Morrissey K, Abi-Saab D, Bremner JD, Bowers MB Jr, Suckow RF, Stetson P, Heninger GR, Charney DS (1998) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacol (Berl) 135:213\u2013229","journal-title":"Psychopharmacol (Berl)"},{"key":"2883_CR16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","volume":"62","author":"JH Krystal","year":"2005","unstructured":"Krystal JH, Perry EB Jr, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D\u2019Souza DC (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985\u2013994","journal-title":"Arch Gen Psychiatry"},{"key":"2883_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00213-005-2179-5","volume":"180","author":"DJ LaPorte","year":"2005","unstructured":"LaPorte DJ, Blaxton TA, Michaelidis T, Robertson DU, Weiler MA, Tamminga CA, Lahti AC (2005) Subtle effects of ketamine on memory when administered following stimulus presentation. Psychopharmacol (Berl) 180:385\u2013390","journal-title":"Psychopharmacol (Berl)"},{"key":"2883_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1037\/1064-1297.14.4.439","volume":"14","author":"MR Lofwall","year":"2006","unstructured":"Lofwall MR, Griffiths RR, Mintzer MZ (2006) Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults. Exp Clin Psychopharmacol 14:439\u2013449","journal-title":"Exp Clin Psychopharmacol"},{"key":"2883_CR19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","volume":"14","author":"DR McLeod","year":"1982","unstructured":"McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 14:463\u2013466","journal-title":"Behav Res Methods Instrum"},{"key":"2883_CR20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00008877-199711000-00014","volume":"8","author":"MZ Mintzer","year":"1997","unstructured":"Mintzer MZ, Frey JM, Yingling JE, Griffiths RR (1997) Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behav Pharmacol 8:561\u2013574","journal-title":"Behav Pharmacol"},{"key":"2883_CR21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00008877-200212000-00007","volume":"13","author":"MZ Mintzer","year":"2002","unstructured":"Mintzer MZ, Griffiths RR (2002) Alcohol and triazolam: differential effects on memory, psychomotor performance and subjective ratings of effects. Behav Pharmacol 13:653\u2013658","journal-title":"Behav Pharmacol"},{"key":"2883_CR22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1037\/1064-1297.11.1.56","volume":"11","author":"MZ Mintzer","year":"2003","unstructured":"Mintzer MZ, Griffiths RR (2003a) Lorazepam and scopolamine: a single-dose comparison of effects on human memory and attentional processes. Exp Clin Psychopharmacol 11:56\u201372","journal-title":"Exp Clin Psychopharmacol"},{"key":"2883_CR23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0269881103017001689","volume":"17","author":"MZ Mintzer","year":"2003","unstructured":"Mintzer MZ, Griffiths RR (2003b) Triazolam\u2013amphetamine interaction: dissociation of effects on memory versus arousal. J Psychopharmacol 17:17\u201329","journal-title":"J Psychopharmacol"},{"key":"2883_CR24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-007-0726-y","volume":"192","author":"MZ Mintzer","year":"2007","unstructured":"Mintzer MZ, Griffiths RR (2007a) A triazolam\/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal. Psychopharmacol (Berl) 192:425\u2013440","journal-title":"Psychopharmacol (Berl)"},{"key":"2883_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3758\/CABN.7.2.120","volume":"7","author":"MZ Mintzer","year":"2007","unstructured":"Mintzer MZ, Griffiths RR (2007b) Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes. Cogn Affect Behav Neurosci 7:120\u2013129","journal-title":"Cogn Affect Behav Neurosci"},{"key":"2883_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1037\/a0018061","volume":"18","author":"MZ Mintzer","year":"2010","unstructured":"Mintzer MZ, Kleykamp BA, Griffiths RR (2010) Dose effects of triazolam and scopolamine on metamemory. Exp Clin Psychopharmacol 18:17\u201331","journal-title":"Exp Clin Psychopharmacol"},{"key":"2883_CR27","first-page":"298","volume":"172","author":"CJ Morgan","year":"2004","unstructured":"Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV (2004a) Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose\u2013response study. Psychopharmacol (Berl) 172:298\u2013308","journal-title":"Psychopharmacol (Berl)"},{"key":"2883_CR28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","volume":"105","author":"CJ Morgan","year":"2010","unstructured":"Morgan CJ, Muetzelfeldt L, Curran HV (2010) Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 105:121\u2013133","journal-title":"Addiction"},{"key":"2883_CR29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.drugalcdep.2004.03.006","volume":"75","author":"CJ Morgan","year":"2004","unstructured":"Morgan CJ, Riccelli M, Maitland CH, Curran HV (2004b) Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. Drug Alcohol Depend 75:301\u2013308","journal-title":"Drug Alcohol Depend"},{"key":"2883_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2008.01.024","volume":"95","author":"L Muetzelfeldt","year":"2008","unstructured":"Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJ, Curran HV (2008) Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend 95:219\u2013229","journal-title":"Drug Alcohol Depend"},{"key":"2883_CR31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)24438-X","volume":"272","author":"GK Mumford","year":"1995","unstructured":"Mumford GK, Rush CR, Griffiths RR (1995) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570\u2013580","journal-title":"J Pharmacol Exp Ther"},{"key":"2883_CR32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1037\/0033-2909.95.1.109","volume":"95","author":"TO Nelson","year":"1984","unstructured":"Nelson TO (1984) A comparison of current measures of the accuracy of feeling-of-knowing predictions. Psychol Bull 95:109\u2013133","journal-title":"Psychol Bull"},{"key":"2883_CR33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0177-2","volume":"183","author":"A Parwani","year":"2005","unstructured":"Parwani A, Weiler MA, Blaxton TA, Warfel D, Hardin M, Frey K, Lahti AC (2005) The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacol (Berl) 183:265\u2013274","journal-title":"Psychopharmacol (Berl)"},{"key":"2883_CR34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.npp.1300642","volume":"30","author":"LM Rowland","year":"2005","unstructured":"Rowland LM, Astur RS, Jung RE, Bustillo JR, Lauriello J, Yeo RA (2005) Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30:633\u2013639","journal-title":"Neuropsychopharmacology"},{"key":"2883_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s002130051030","volume":"145","author":"CR Rush","year":"1999","unstructured":"Rush CR, Frey JM, Griffiths RR (1999) Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacology 145:39\u201351","journal-title":"Psychopharmacology"},{"key":"2883_CR36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/0096-3445.117.1.34","volume":"117","author":"JG Snodgrass","year":"1988","unstructured":"Snodgrass JG, Corwin J (1988) Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol Gen 117:34\u201350","journal-title":"J Exp Psychol Gen"},{"key":"2883_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0001-6918(69)90055-9","volume":"30","author":"S Sternberg","year":"1969","unstructured":"Sternberg S (1969) The discovery of processing stages: extensions of Donder\u2019s method. Acta Psychologica 30:276\u2013315","journal-title":"Acta Psychologica"},{"key":"2883_CR38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose response study of N, N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51:98\u2013108","journal-title":"Arch Gen Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2883-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2883-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2883-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:09:08Z","timestamp":1745064548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2883-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2883"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2883-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}